ΒΙΟΓΡΑΦΙΚΟ. Εκπαίδευση

Transcript

1 ΒΙΟΓΡΑΦΙΚΟ Εκπαίδευση Πανεπιστημιακή εκπαίδευση στην Ιατρική Σχολή του Πανεπιστημίου Φλωρεντίας. Μεταπτυχιακή εκπαίδευση πάνω στους φυσιοπαθολογικούς μηχανισμούς των συστηματικών αυτοάνοσων νοσημάτων στο Center of excellence for the study at molecular and clinical level of chronic, degenerative and neoplastic diseases to develop novel therapies, Florence, Italy. Ειδίκευση στην Αλλεργιολογία στο Τμήμα Αλλεργιολογίας και κλινικής Ανοσολογίας του Πανεπιστημίου Φλωρεντίας. Επαγγελματική εμπειρία Υπεύθυνος Αλλεργιολογικού Ιατρείου Βούλας Επικουρικός Αλλεργιολόγος στη Μονάδα Αλλεργιολογίας της Β Κλινικής Αφροδισίων και Δερματικών Νόσων Πανεπιστημίου Αθηνών, Π.Γ.Ν. «Αττικόν» Επιστημονικός Συνεργάτης Μονάδας Αλλεργιολογίας της Β Κλινικής Αφροδισίων και Δερματικών Νόσων Πανεπιστημίου Αθηνών, Π.Γ.Ν. «Αττικόν» Οργάνωση συνεδρίων 8th annual congress "Advances in Allergy", Volos, March 2015, Greece 7th annual congress "Advances in Allergy", Kalampaka, November 2013, Greece 1η Μετεκπαιδευτική Ημερίδα Φαρμακευτικής Αλλεργίας "Φαρμακευτική αλλεργία, μια ιατρογενής νόσος. 28 Σεπτεμβρίου 2013, Αίγλη Ζαππείου 6th annual congress "Advances in Allergy", Thessaloniki, November 2012, Greece 5th annual congress "Advances in allergy", Patras, 7-8 October 2011, Greece Σημαντικές διακρίσεις 2ο βραβείο στο 10ο Πανελλήνιο Συνέδριο Αλλεργιολογίας & Κλινικής Ανοσολογίας (Αθήνα, 2014) για τη μελέτη με τιτλο "Καταγραφή ευαισθητοποίησης στο δηλητήριο της μέλισσας στους έλληνες μελισσοκόμους". 1ο βραβείο στο 9ο Πανελλήνιο Συνέδριο Αλλεργιολογίας & Κλινικής Ανοσολογίας (Αθήνα, 2012) για τη μελέτη με τίτλο "Αποτελεσματικότητα και ασφάλεια του omalizumab στο σοβαρό αλλεργικό άσθμα σε ασθενείς με εποχική παρόξυνση."

2 Συμμετοχή σε Επιστημονικούς Οργανισμούς Μέλος Ευρωπαϊκής Ακαδημίας Αλλεργιολογίας & Κλινικής Ανοσολογίας (EAACI) Μέλος Ελληνικής Εταιρίας Αλλεργιολογίας & Κλινικής Ανοσολογίας (ΕΕΑΚΑ) Διαλέξεις & ομιλίες σε συνέδρια 2015 Biological agents for asthma: Biological therapies for asthma-current status and future prospects. 8th annual congress "Advances in Allergy", Volos March, 2015 Greece Mast-cell activation disorders- Διαδικτυακά Μετεκπαιδευτικά Μαθήματα Ελληνικής Εταιρίας Αλλεργιολογίας & Κλινικής Ανοσολογίας, Hypersensitivity reactions to biologicals. 10th Hellenic Congress of Allergy and Clinical Immunology, Οctober 2014, Αthens From xenobiotics to biologicals: novel therapeutic approaches, Focused meeting by the Hellenic Society of Allergy and Clinical Immunology,14 December 2014, Athens Διαταραχές ανοσορρύθμισης. Αυτοανοσία και αλλεργία - Διαδικτυακά Μετεκπαιδευτικά Μαθήματα Ελληνικής Εταιρίας Αλλεργιολογίας & Κλινικής Ανοσολογίας, 2013 Current guidelines for the treatment of atopic dermatitis. 7th annual congress "Advances in Allergy", Kalampaka, November, Greece Reactions to radiocontrast media. 1st meeting on Drug Allergy, Hellenic Society of Allergy and Clinical Immunology, 28 September, Athens Food allergy and atopic dermatitis, 6th annual congress "Advances in Allergy", Thessaloniki, november, Greece

3 Difficult cases. Interactive session. 9th Hellenic Congress of Allergy and Clinical Immunology, Οctober 2012, Αthens. Severe asthma phenotypes and therapeutic approaches. "Basic immunology leads clinical practice. Focused meeting organized by the Hellenic Association of Allergy and Clinical Immunology (EEAKA) 2011 Atopic dermatitis: novel therapeutic approaches: what have we learned from the pathogenetic mechanisms of the disease. 5th annual congress "Advances in Allergy" Patras,7-8 October, Greece 2007 Rituximab (anti-cd20) therapy for refractory pancytopenia in patients with systemic lupus erythematosus "Emerging therapies for autoimmune diseases" 22 september 2007 Florence, Italy Hemolymphophagocytic syndrome in adult's Still disease. Overview on Systemic autoimmune diseases, october 2006, Florence, Italy. Infliximab for the treatment of recalcitrant uveitis in Behcet's disease. "Update on Behcet Disease" 20 november 2006 Florence, Italy. Επιστημονικές Δημοσιεύσεις και Ανακοινώσεις 1. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, Eiwegger T, Firinu D, Harr T, Knol E, Matucci A, Palomares O, Schmidt-Weber C, Simon HU, Steiner UC, Vultaggio A, Akdis CA, Spertini F. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy Mar 26. doi: /all Chatzipetrou A, Gkavogiannakis N, Skarlatou G, Makris Michael. Mast cell load and the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis. EAACI 2014 (poster discussion) 3. Gkavogiannakis N, Potika, Makris M, Chatzipetrou A. Level of serum IgE and serum tryptase in patients with mastocytosis: a retrospective analysis in Greek population. EAACI 2014 (oral presentation) 4. Koulias C, Potika M, Chliva K, Aggelidis X, Chatzipetrou A, Makris M. Hypersensitivity reactions to iodinated contrast media EAACI- WAO 2013, Milan (poster discussion)

4 5. Potika M, Guibas G, Koulias C, Zeliou CG Chatzipetrou A, Aggelides X, Makris M, The clinical pattern of non steroidal antiinflammatory drugs hypersensitivity and outcomes of pertinent oral challenges. EAACI-WAO 2013 (Poster) 6. Potika M, Guibas G, Tsilochristou O, Skarlatou G, Chatzipetrou A Chliva C, Makris M. Compliance of non steroidal antiinflammatory drugs patients to drug related instructions a phone survey EAACI- WAO 2013 (poster) 7. Koulias C,Guibas G, Potika M, Aggelides X, Makris M. Severe immediate hypersensitivity to diclophenac with systemic reaction to intradermal testing. A case report. EAACI-WAO 2013 (poster) 8. Zeliou CG, Skarlatou G, Aggelides X, Chatzipetrou A, Makris M. Anaphylactic reactions to ranitidine: report of two cases. EAACI- WAO 2013 (poster). 9. Chatzipetrou A, Koulias C, Zeliou CG, Potika M, Chliva K, Makris M. Childhood mastocytosis: serum baseline total tryptase levels and extent of cutaneous disease as predictors of mast cell mediator release symptoms PAAM 2013, Athens (poster discussion) 10. Chatzipetrou A, Koulias C, Kogkas S, Chliva C, Guibas G, Aggelides X, Makris M (2012) Anaphylaxis in patients with mastocytosis: incidence eliciting factors, severity and risk factors, EAACI 2012, Geneva, Switzerland, p 198: Abstract no 1509 (poster) 11. Chatzipetrou A, Tsilochristou O, Kogkas, Chyrtiroglou E, S Koulias C Chliva C, Aggelides X, Makris M, (2012) Outcomes of drug provocation tests: three-year retrospective analysis, Drug Hypersensitivity Meeting, Munich, Germany, p: Abstract no P81 (poster) 12. Koulias C, Tsilochristou O, Chliva C, Zeliou C, Chatzipetrou A, Aggelides X, Makris M Partially Hydrolysed formulas in cow's milk allergic children (2012) EAACI 2012, Geneva, Switzerland, p 50: Abstract no 260 (oral) 13. Kogkas S, Retsas P, Liapis C, Chatzipetrou A, Aggelides X, Chliva C, Makris M Clinical efficacy and safety of omalizumab in severe allergic asthma. (2012) EAACI 2012, Geneva, Switzerland, p 178: Abstract no 1218 (poster) 14. Guibas G, Makris M, Chliva C, Chatzipetrou A, Priftis K, Sensitisation of weanling, but not adult rats, following nonadjuvant-aided airway exposure to inert aeroallergen. (2011) PAAM 2011, Barcellona, Spain, p 40, Abstract no PD32 (oral) 15. Tsilochristou O, Chliva C, Chyrtiroglou E, Chatzipetrou A, Guibas G, Aggelides X, Makris M. Rectal Bleeding in infancy: Clinical

5 features, managements and natural course (2011) PAAM 2011, Barcellona, Spain (oral) 16. Valsamaki P, Zanglis A, Chatzipetrou A, Vlachou C, Fountos G, Gerali S, (2010) Aminoterminal propeptide of type 1 procollagen and bone densitometry in assessing fracture risk in postmenopausal women with thyroxine-induced subclinical hyperthyroidism; efficacyof antiresorptive treatment, Annual congress of the european association of nuclear medicine,vienna, Austria, p 192, Abstract n P575 (poster) Greek Meetings Chatzipetrou A Gkavoyannakis N, Scarlatou G Chliva K, Makris M. Mastocytosis and hymenoptera venum anaphylaxis: friends or enemies. 10th Hellenic Congress of Allergy and Clinical Immunology, October 2014, Athens (oral presentation) 18. Gkavoyannakis N, Vasilatou E, Chatzipetrou A, Kontogiorgaki I, Koulias C, Makris M, Chatzidakis D, Rigopoulos D. Bone metabolism and mastocytosis. 10th Hellenic Congress of Allergy and Clinical Immunology, October 2014, Athens (poster) 19. Gkavoyannakis N, Potika M, Makris M, Chatzipetrou A.Total Ig E levels and basal serum tryptase levels in patints affected by mastocytosis. 10th Hellenic Congress of Allergy and Clinical Immunology, October 2014, Athens (poster) 20. Gkavoyannakis N, Scarlatou S, Chatzipetrou A, Chliva K, Makris M, Annual fluctuation of serum basal tryptase levels in mastocytosis patients undergoing hymenoptera venum immunotherapy 10th Hellenic Congress of Allergy and Clinical Immunology, October 2014, Athens (oral) 21. Chatzipetrou A, Tsilochristou O, Kogkas, Chyrtiroglou E, S Koulias C Chliva C, Aggelides X, Makris M, (2012) Safety and clinical value of drug provocation tests in a population with well characterized drug hypersensitivity reaction:, 9th Hellenic Congress of Allergy and Clinical Immunology, October 2012, Athens pg 30 AA09 (poster)

6 22. Koulias C, Tsilochristou O, Chatzipetrou A, Zeliou C, Guibbas G, Chliva K. Partially Hydrolysed formulas in cow's milk allergic children 9th Hellenic Congress of Allergy and Clinical Immunology, October 2012, Athens pg 30 AA09 (poster) pg30 ΑΑ13 (poster) 23. Kogkas S, Retsas P, Liapis C, Chatzipetrou A, Aggelides X, Makris M, (2012). "Safety and efficacy of omalizumab therapy in patients with severe allergic asthma and seasonal exacerbations." 9th Hellenic Congress of Allergy and Clinical Immunology, October 2012, Athens pg 33 ΑΑ29 (poster) 24. Guibbas G, Makris M, Chliva K, Chatzipetrou A, Priftis K. Sensitization of weaning rats but not adult rats after respiratory exposure to inert aeroallergens. (2011) 2nd Hellenic congress of pediatric allergy Volos, Greece. (poster) 25. Chatzipetrou A, L. Emmi, A. Pupi. (2010) ([18F]FDGPET) in patients with systemic lupus erythematosus.." 8th Hellenic Congress of Allergy and Clinical Immunology, October 2012, Athens (poster) 26. Chatzipetrou Α, Cristina Polito, L.Emmi, A.Pupi.. Cerebral hypometabolism areas detected by(18)f-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings 10th Hellenic Congress of Nuclear Medicine Kalambaka 2010, pg 16, AA51 (poster pg 16, AA51)